Tony Wang
About Tony Wang
Tony Wang is an Oncology Medical professional at Bristol-Myers Squibb in the Pacific Northwest, with a background in regulatory affairs and extensive education in law, pharmacy, and biology.
Current Role at Bristol-Myers Squibb
Tony Wang is currently serving as the Oncology Medical, Health Systems professional at Bristol-Myers Squibb in the Pacific Northwest. In this role, he is responsible for formulating and executing strategies to maintain open access for BMS products on national Oncology Clinical Pathway products, including the McKesson Clear Value Pathway. He also leads the lung cancer therapeutic area, shaping organizational strategic goals using field-facing team and key opinion-leader insights.
Previous Experience at Kaiser Permanente
From 2003 to 2015, Tony Wang worked at Kaiser Permanente as the Director of Regulatory Affairs. During his 12-year tenure, he led the development and oversight of living cross-matrix Institutional Account MAPs to coordinate and streamline touchpoints with key account customers at national healthcare institutions such as Kaiser Permanente and Sutter Health. His role required extensive regulatory expertise and strategic planning.
Educational Background
Tony Wang holds advanced degrees in both Law and Pharmacy. He earned his Doctor of Law (JD) degree from Loyola Law School, Los Angeles, where he studied from 2008 to 2012. Earlier, he obtained his Doctor of Pharmacy (Pharm.D.) degree from the University of California, San Francisco, completing his studies from 1997 to 2001. Additionally, he holds a Bachelor of Science (BS) in Biology, General from the University of California, Los Angeles, where he studied from 1993 to 1997.
Strategic Initiatives and Leadership
Tony Wang has demonstrated significant leadership in strategic initiatives. At Bristol-Myers Squibb, he collaborates extensively to craft and oversee new employee onboarding programs. During his tenure at Kaiser Permanente, he was instrumental in developing strategies to streamline interactions with key account customers in national healthcare institutions. His leadership is marked by a collaborative approach and a focus on achieving organizational goals.